XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2024
Mar. 31, 2024
CURRENT ASSETS    
Cash $ 173,270 $ 786,060
Accounts receivable, net 1,499,990 1,468,655
Inventory [Note 3] 1,817,561 1,879,402
Deposits and other receivables 573,674 336,456
Total current assets 4,064,495 4,470,573
Deposits and other receivables [Note 10] 112,972 85,000
Long-term accounts receivable 78,699 149,907
Property and equipment [Note 12] 12,576 15,552
Operating right of use assets [Note 10] 1,023,318 1,221,593
TOTAL ASSETS 5,292,060 5,942,625
CURRENT LIABILITIES    
Accounts payable and accrued liabilities [Note 4] 9,057,028 9,473,118
Convertible promissory notes and short term loans [Note 5] 8,479,032 9,376,471
Term loan, current 3,000,000 2,400,000
Derivative liabilities [Note 8] 460,059 991,866
Operating lease obligations, current [Note 10] 493,190 457,371
Total current liabilities 21,489,309 22,698,826
Federally guaranteed loans [Note 7] 870,800 870,800
Term loan [Note 6] 9,489,491 9,985,033
Derivative liabilities [Note 8] 1,649,177 1,435,668
Operating lease obligations 674,013 929,115
TOTAL LIABILITIES 34,172,790 35,919,442
MEZZANINE EQUITY    
Series B Convertible Redeemable preferred stock, $0.001 par value, 600 shares authorized as of September 30, 2024 and March 31, 2024, respectively, 405 and 265 shares issued and outstanding as of September 30, 2024 and March 31, 2024, respectively [Note 9] 2,286,105 1,488,920
STOCKHOLDERS’ DEFICIENCY    
Common stock, $0.001 par value, 125,000,000 shares authorized as at September 30, 2024, and March 31, 2024, respectively. Issued and outstanding common shares: 22,863,261 and 9,353,768 as at September 30, 2024 and March 31, 2024, respectively, and exchangeable shares of 160,672 outstanding as at September 30, 2024 and March 31, 2024, respectively [Note 9] 23,024 9,515
Shares to be issued 194,998 and 324,276 shares of common stock as at September 30, 2024 and March 31, 2024, respectively) [Note 9] 142,537 269,065
Additional paid-in-capital 104,842,124 95,723,083
Accumulated other comprehensive (loss) / income (73,415) 32,378
Accumulated deficit (136,101,106) (127,499,785)
Total stockholders’ deficiency (31,166,835) (31,465,737)
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIENCY 5,292,060 5,942,625
Preferred Stock [Member]    
STOCKHOLDERS’ DEFICIENCY    
Preferred stock, value 1 1
Series A Preferred Stock [Member]    
STOCKHOLDERS’ DEFICIENCY    
Preferred stock, value $ 0 $ 6